These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18260802)

  • 1. A ten-year analysis of the incidence and risk factors for acute pancreatitis requiring hospitalization in an urban HIV clinical cohort.
    Riedel DJ; Gebo KA; Moore RD; Lucas GM
    AIDS Patient Care STDS; 2008 Feb; 22(2):113-21. PubMed ID: 18260802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort.
    Gebo KA; Burkey MD; Lucas GM; Moore RD; Wilson LE
    J Acquir Immune Defic Syndr; 2006 Dec; 43(4):426-32. PubMed ID: 17099314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute pancreatitis associated with different combination therapies in patients infected with human immunodeficiency virus.
    Guo JJ; Jang R; Louder A; Cluxton RJ
    Pharmacotherapy; 2005 Aug; 25(8):1044-54. PubMed ID: 16207094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/microL).
    Floridia M; Bucciardini R; Fragola V; Galluzzo CM; Giannini G; Pirillo MF; Amici R; Andreotti M; Ricciardulli D; Tomino C; Vella S;
    HIV Med; 2004 Jan; 5(1):1-10. PubMed ID: 14731162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone.
    Jones R; Sawleshwarkar S; Michailidis C; Jackson A; Mandalia S; Stebbing J; Bower M; Nelson M; Gazzard BG; Moyle GJ
    HIV Med; 2005 Nov; 6(6):396-402. PubMed ID: 16268821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
    Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospitalization in HIV in Chicago.
    Sherer R; Pulvirenti J; Stieglitz K; Narra J; Jasek J; Green L; Moore B; Shott S; Cohen M
    J Int Assoc Physicians AIDS Care (Chic); 2002; 1(1):26-33. PubMed ID: 12942666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs.
    Moore RD; Keruly JC; Chaisson RE
    AIDS; 2001 Mar; 15(5):617-20. PubMed ID: 11316999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignancy in perinatally human immunodeficiency virus-infected children in the United States.
    Kest H; Brogly S; McSherry G; Dashefsky B; Oleske J; Seage GR
    Pediatr Infect Dis J; 2005 Mar; 24(3):237-42. PubMed ID: 15750460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholelithiasis and Nephrolithiasis in HIV-Positive Patients in the Era of Combination Antiretroviral Therapy.
    Lin KY; Liao SH; Liu WC; Cheng A; Lin SW; Chang SY; Tsai MS; Kuo CH; Wu MR; Wang HP; Hung CC; Chang SC
    PLoS One; 2015; 10(9):e0137660. PubMed ID: 26360703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low effectiveness of highly active antiretroviral therapy and high mortality in the Greenland HIV-infected population.
    Lohse N; Ladefoged K; Pedersen L; Jensen-Fangel S; Sørensen HT; Obel N
    Scand J Infect Dis; 2004; 36(10):738-42. PubMed ID: 15513400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of combination antiretroviral therapies on the risk of myocardial infarction among HIV patients.
    Brouwer ES; Napravnik S; Eron JJ; Stalzer B; Floris-Moore M; Simpson RJ; Stürmer T
    Epidemiology; 2014 May; 25(3):406-17. PubMed ID: 24713880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends and causes of hospitalizations among HIV-infected persons during the late HAART era: what is the impact of CD4 counts and HAART use?
    Crum-Cianflone NF; Grandits G; Echols S; Ganesan A; Landrum M; Weintrob A; Barthel R; Agan B;
    J Acquir Immune Defic Syndr; 2010 Jul; 54(3):248-57. PubMed ID: 20658748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of acute pancreatitis in human immunodeficiency virus-positive patients with hypertriglyceridemia: is it really high?
    Sun HY; Chang SY; Sheng WH; Chen MY; Hsieh SM; Tseng YT; Lu CL; Yang CJ; Wu H; Liu WC; Wu CH; Hung CC; Chang SC
    Pancreas; 2012 Mar; 41(2):283-9. PubMed ID: 22343978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year outcomes of children on non-nucleoside reverse transcriptase inhibitor and protease inhibitor regimens in a South African pediatric antiretroviral program.
    Jaspan HB; Berrisford AE; Boulle AM
    Pediatr Infect Dis J; 2008 Nov; 27(11):993-8. PubMed ID: 18818556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy.
    Gebo KA; Diener-West M; Moore RD
    J Acquir Immune Defic Syndr; 2001 Jun; 27(2):143-52. PubMed ID: 11404536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era.
    Gebo KA; Kalyani R; Moore RD; Polydefkis MJ
    J Acquir Immune Defic Syndr; 2005 Oct; 40(2):169-74. PubMed ID: 16186734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy.
    Puthanakit T; Aurpibul L; Oberdorfer P; Akarathum N; Kanjananit S; Wannarit P; Sirisanthana T; Sirisanthana V
    Clin Infect Dis; 2007 Feb; 44(4):599-604. PubMed ID: 17243067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study.
    Young J; Rickenbach M; Weber R; Furrer H; Bernasconi E; Hirschel B; Tarr PE; Vernazza P; Battegay M; Bucher HC
    Antivir Ther; 2005; 10(1):73-81. PubMed ID: 15751765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.